Association between total prostate‐specific antigen (tPSA), free/tPSA, and prostate cancer mortality-Reference-Cited by-同舟云学术

Association between total prostate‐specific antigen (tPSA), free/tPSA, and prostate cancer mortality

Published:2022-03 Issue:3 Volume:129 Page:418-418
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

Ferraro Simona¹^ORCID,Biganzoli Elia Mario²

Affiliation:

1. Department of Laboratory Medicine ASST Fatebenefratelli‐Sacco “Luigi Sacco” University Hospital, Università degli Studi di Milano Milan Italy

2. Medical Statistics Unit Department of Biomedical and Clinical Sciences L. Sacco “Luigi Sacco” University Hospital, Università degli Studi di Milano Milan Italy

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15611

Reference8 articles.

1. Association between one‐time prostate‐specific antigen (PSA) test with free/total PSA ratio and prostate cancer mortality: a 30‐year prospective cohort study;Lundgren PO;BJU Int,2021

2. Dual‐label time‐resolved immunofluorometric assay of free and total prostate‐specific antigen based on recombinant Fab fragments;Eriksson S;Clin Chem,2000

3. Serum prostate specific antigen (PSA) testing for early detection of prostate cancer: managing the gap between clinical and laboratory practice;Ferraro S;Clin Chem,2021

4. Variability of assay methods for total and free PSA after WHO standardization;Foj L;Tumour Biol,2014

5. Verification of harmonization of serum total and free prostate‐specific antigen (PSA) measurements and implications for medical decisions;Ferraro S;Clin Chem,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fish consumption and risk of prostate cancer or its mortality: an updated systematic review and dose–response meta-analysis of prospective cohort studies;Frontiers in Nutrition;2023-08-01

2. Managing the impact of inter-method bias of prostate specific antigen assays on biopsy referral: the key to move towards precision health in prostate cancer management;Clinical Chemistry and Laboratory Medicine (CCLM);2022-11-02